Wis. maker of ablation devices nears financing target of $19M

08/1/2013 | MassDevice.com (Boston)

An equity financing round targeted at $19 million has pulled in $14 million for NeuWave Medical, a spinoff of the University of Wisconsin-Madison. The company is the maker of the Certus 140 soft-tissue ablation system, which is used primarily to aid in the treatment of kidney, liver and lung tumors.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN